SEARCH

SEARCH BY CITATION

References

  • Adilakshmi T, Ayling PD & Ratledge C (2000) Mutational analysis of a role for salicylic acid in iron metabolism of Mycobacterium smegmatis. J Bacteriol 182: 264271.
  • Boelaert JR, Vandecasteele SJ, Appelberg R & Gordeuk VR (2007) The effect of the host's iron status on tuberculosis. J Infect Dis 195: 17451753.
  • Brown KA & Ratledge C (1975) The effect of p-aminosalicyclic acid on iron transport and assimilation in mycobacteria. Biochim Biophys Acta 385: 207220.
  • De Voss JJ, Rutter K, Schroeder BG, Su H, Zhu Y & Barry CE III (2000) The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. P Natl Acad Sci USA 97: 12521257.
  • Kulkarni VM & Seydel JK (1983) Inhibitory activity and mode of action of diaminodiphenylsulfone in cell-free folate-synthesizing systems prepared from Mycobacterium lufu and Mycobacterium leprae. A comparison. Chemotherapy 29: 5867.
  • Lehmann J (1946) p-Aminosalicylic acid in the treatment of tuberculosis. Lancet 1: 1516.
  • Luo M, Fadeev EA & Groves JT (2005) Mycobactin-mediated iron acquisition within macrophages. Nat Chem Biol 1: 149153.
  • Mathys V, Wintjens R, Lefevre P et al. (2009) Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis. Antimicrob Agents Ch 53: 21002109.
  • McDermid JM & Prentice AM (2006) Iron and infection: effects of host iron status and the iron-regulatory genes haptoglobin and NRAMP1 (SLC11A1) on host–pathogen interactions in tuberculosis and HIV. Clin Sci (London) 110: 503524.
  • Morrison NE (1971) Sequential blockade of the mycobacterial de novo folate pathway. A review. Int J Leprosy 39: 3443.
  • Nagachar N & Ratledge C (2010) Roles of trpE2, entC and entD in salicylic acid biosynthesis in Mycobacterium smegmatis. FEMS Microbiol Lett 308: 159165.
  • Patole J, Shingnapurkar D, Padhye S & Ratledge C (2006) Schiff base conjugates of p-aminosalicylic acid as antimycobacterial agents. Bioorg Med Chem Lett 16: 15141517.
  • Payne RJ, Bulloch EM, Toscano MM, Jones MA, Kerbarh O & Abell C (2009) Synthesis and evaluation of 2,5-dihydrochorismate analogues as inhibitors of the chorismate-utilising enzymes. Org Biomol Chem 7: 24212429.
  • Quadri LE, Sello J, Keating TA, Weinreb PH & Walsh CT (1998) Identification of a Mycobacterium tuberculosis gene cluster encoding the biosynthetic enzymes for assembly of the virulence-conferring siderophore mycobactin. Chem Biol 5: 631645.
  • Ratledge C (1999) Iron metabolism. Mycobacteria: Molecular Biology and Virulence (RatledgeC & DaleJ, eds), pp. 260286. Blackwell Science, Oxford, UK.
  • Ratledge C (2004) Iron, mycobacteria and tuberculosis. Tuberculosis 84: 110130.
  • Ratledge C & Brown KA (1972) Inhibition of mycobactin formation in Mycobacterium smegmatis by p-aminosalicylate. A new proposal for the mode of action of p-aminosalicylate. Am Rev Respir Dis 106: 774776.
  • Ratledge C & Dover LG (2000) Iron metabolism in pathogenic bacteria. Annu Rev Microbiol 54: 881941.
  • Ratledge C & Ewing M (1996) The occurrence of carboxymycobactin, the siderophore of pathogenic mycobacteria, as a second extracellular siderophore in Mycobacterium smegmatis. Microbiology 142: 22072212.
  • Ratledge C & Hall MJ (1971) Influence of metal ions on the formation of mycobactin and salicylic acid in Mycobacterium smegmatis grown in static culture. J Bacteriol 108: 314319.
  • Ratledge C & Hall MJ (1972) Isolation and properties of auxotrophic mutants of Mycobacterium smegmatis requiring either salicylic acid or mycobactin. J Gen Microbiol 72: 143150.
  • Rees RJ (1967) Drug resistance of Mycobacterium leprae, particularly to DDS. Int J Leprosy 35: 625638.
  • Rengarajan J, Sassetti CM, Naroditskaya V, Sloutsky A, Bloom BR & Rubin EJ (2004) The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria. Mol Microbiol 53: 275282.
  • Schaible UE & Kaufmann SH (2004) Iron and microbial infection. Nat Rev Microbiol 2: 946953.
  • Snow GA (1965) Isolation and structure of mycobactin T, a growth factor from Mycobacterium tuberculosis. Biochem J 97: 166175.
  • Somu RV, Boshoff H, Qiao C, Bennett EM, Barry CE III & Aldrich CC (2006) Rationally designed nucleoside antibiotics that inhibit siderophore biosynthesis of Mycobacterium tuberculosis. J Med Chem 49: 3134.
  • Winder FG (1964) The antimicrobial action of streptomycin, isoniazid and PAS. Chemotherapy of Tuberculosis (BarryVC, ed.), pp. 111149. Butterworth, London.
  • Winder FG (1982) Mode of action of the antimycobacterial agents and associated aspects of the molecular biology of the mycobacteria. The Biology of the Mycobacteria, Vol. 1 (RatledgeC & StanfordJ, eds), pp. 353438. Academic Press, London.